RenX Enterprises (Nasdaq: RENX) extends warrant approval and SEC registration deadlines
Filing Impact
Filing Sentiment
Form Type
8-K
Rhea-AI Filing Summary
RenX Enterprises Corp. entered into consent and waiver agreements with the institutional investors from its February 17, 2026 private placement of senior convertible promissory notes and warrants. The Investors agreed to extend several key deadlines tied to stockholder approval and registration of shares underlying the notes and warrants.
The deadline to file a proxy statement seeking stockholder approval of the exercise of certain Second Warrants is extended from 45 to 73 days after the Closing Date. The deadline to hold the stockholder meeting is extended from 90 to 118 days after the Closing Date. The date by which the initial registration statement for shares issuable upon conversion and exercise of the notes and certain warrants must be declared effective is extended from 45 to 57 days after the Closing Date, or 75 days if the SEC conducts a full review. RenX also agreed to file a new Form S-3 registration statement to register for resale the shares issuable upon exercise of the Second Warrants on or before the tenth calendar day after obtaining the required stockholder approval, while all other Private Placement terms remain in effect.
Positive
- None.
Negative
- None.
8-K Event Classification
Item 8.01 — Other Events
1 item
Item 8.01
Other Events
Other
Voluntary disclosure of events the company deems important to shareholders but not covered by other items.
Key Figures
Proxy statement filing deadline: 73 days after February 17, 2026
Stockholder meeting deadline: 118 days after February 17, 2026
Registration effectiveness deadline: 57 days after February 17, 2026
+2 more
5 metrics
Proxy statement filing deadline
73 days after February 17, 2026
Extended from 45 days after the Closing Date
Stockholder meeting deadline
118 days after February 17, 2026
Extended from 90 days after the Closing Date
Registration effectiveness deadline
57 days after February 17, 2026
Extended from 45 days; 75 days if SEC conducts full review
New Form S-3 timing
On or before tenth calendar day
After obtaining requisite stockholder approval for Second Warrant exercise
Agreement dates
April 8 and April 9, 2026
Dates RenX entered into consent and waiver agreements with Investors
Key Terms
consent and waiver agreement, senior convertible promissory notes, Private Placement, Stockholder Approval, +2 more
6 terms
consent and waiver agreement financial
"entered into a consent and waiver agreement (the “Agreement”) with each of the institutional investors"
senior convertible promissory notes financial
"institutional investors ... purchased senior convertible promissory notes and warrants from the Company"
A senior convertible promissory note is a formal IOU where a company borrows money and promises to repay it, with this loan getting first priority for repayment if the company runs into trouble. The note also gives the lender the option to swap the debt for company shares, like turning an IOU into ownership, which can dilute existing shareholders. Investors care because it affects a company’s cash needs, its risk profile (higher priority reduces lender risk), and the potential for future share dilution if conversion occurs.
Private Placement financial
"that private placement (the “Private Placement”) of securities of the Company that closed on February 17, 2026"
A private placement is a way for companies to raise money by selling securities directly to a small group of investors instead of through a public offering. This process is often quicker and less regulated, making it similar to offering a special, exclusive investment opportunity to select individuals or institutions. For investors, it can provide access to unique investment options that are not available on public markets.
Stockholder Approval financial
"file a proxy statement ... to obtain stockholder approval (“Stockholder Approval”) of the exercise of certain of the warrants"
Stockholder approval is formal consent given by a company’s shareholders, usually through a vote at a meeting or by proxy, for major actions such as mergers, asset sales, changes to corporate structure, or amendments to governance rules. Investors pay attention because the vote can enable or block steps that materially change a company’s direction, ownership or value—like neighbors voting to allow a major renovation that would alter a building’s use and worth.
Second Warrants financial
"the exercise of certain of the warrants (the “Second Warrants”) sold and issued to the Investors in the Private Placement"
registration statement on Form S-3 regulatory
"file a new registration statement on Form S-3 to register for resale by the Investors"
A registration statement on Form S‑3 is a short, standardized filing a qualified public company uses to register new securities with regulators so they can be sold to investors; think of it as a pre-approved, reusable permission slip that speeds up future offerings. It matters to investors because it lets the company raise money more quickly and cheaply — which can fund growth or pay debt — but may also lead to share dilution or change in ownership, so it affects value and liquidity.
FAQ
What did RenX Enterprises Corp. change in its April 2026 agreements with investors?
RenX Enterprises Corp. signed consent and waiver agreements extending several deadlines linked to its February 17, 2026 private placement. These extensions cover proxy filing, the stockholder meeting for warrant approval, and the effectiveness of a registration statement for shares underlying notes and warrants.
How were RenX (RENX) proxy and stockholder meeting deadlines extended?
The proxy statement filing deadline for stockholder approval of exercising certain Second Warrants was extended from 45 to 73 days after the February 17, 2026 Closing Date. The deadline to hold the stockholder meeting for that approval was extended from 90 to 118 days after the same Closing Date.
What changes were made to RenX Enterprises’ registration statement timing?
The deadline for RenX’s initial registration statement to be declared effective, covering shares issuable upon conversion and exercise of notes and certain warrants, was extended from 45 to 57 days after the Closing Date, or 75 days if the SEC conducts a full review of the registration statement.
Do the consent and waiver agreements alter other private placement terms for RENX?
Aside from the extended deadlines and the new Form S-3 registration obligation, all other terms of the transaction documents from the February 17, 2026 private placement remain in full force and effect. The core economic and structural features of the notes and warrants are unchanged by these agreements.